| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.91B | 29.29B | 25.00B | 20.13B | 26.16B | 20.79B |
| Gross Profit | 30.30B | 29.29B | 25.00B | 20.13B | 26.16B | 20.79B |
| EBITDA | 9.64B | 10.13B | 8.88B | 5.90B | -2.92B | -2.75B |
| Net Income | 6.28B | 5.99B | 5.73B | 3.56B | -3.32B | -3.11B |
Balance Sheet | ||||||
| Total Assets | 120.35B | 116.18B | 112.42B | 68.60B | 67.82B | 54.50B |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 17.23B | 24.42B | 5.72B | 3.76B | 2.06B |
| Total Debt | 1.23B | 1.29B | 110.00M | 110.00M | 7.00M | 11.00M |
| Total Liabilities | 25.03B | 24.06B | 21.54B | 53.03B | 45.75B | 38.70B |
| Stockholders Equity | 95.31B | 92.11B | 90.87B | 75.69B | 22.07B | 15.81B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 6.10B | 5.23B | 2.12B | 2.27B | 2.11B |
| Operating Cash Flow | 0.00 | 7.28B | 6.02B | 2.68B | 2.78B | 2.94B |
| Investing Cash Flow | 0.00 | -14.29B | -3.44B | 763.00M | -7.75B | -10.44B |
| Financing Cash Flow | 0.00 | -164.00M | 9.68B | -109.00M | 9.67B | 8.88B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥7.74B | 19.29 | ― | 2.85% | 12.33% | -15.46% | |
72 Outperform | ¥1.68T | 11.39 | ― | 2.44% | -21.38% | 58.05% | |
69 Neutral | ¥4.80T | 11.80 | 10.61% | 3.26% | -8.02% | 5.21% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥155.14B | 21.38 | ― | ― | 20.22% | 19.40% | |
65 Neutral | ¥50.86B | 19.44 | 6.16% | 1.10% | 13.99% | 85.66% | |
61 Neutral | ¥1.88T | 14.60 | 8.83% | 2.74% | -1.96% | 10.32% |
Lifenet Insurance Company has announced the launch and renewal of its cancer insurance products, set to take effect on December 1, 2025. The new offerings include term cancer insurance products and renewed whole-life cancer insurance, aimed at addressing the financial burdens of cancer treatment and adapting to the shift from inpatient to outpatient care. This initiative reflects Lifenet’s commitment to providing customer-oriented products and is expected to have a minor impact on the company’s fiscal performance.
Lifenet Insurance Company reported a strong financial performance for the second quarter of fiscal 2025, with increased insurance revenue and net income. The company’s annualized premium for policies-in-force grew, driven by both individual life insurance and group credit life insurance. The results indicate a positive trend in business growth and profitability, with implications for enhanced stakeholder value.
Lifenet Insurance Company reported a 10% increase in the annualized premium of policies-in-force for October 2025 compared to the previous year, reaching 35,993 million yen. This growth reflects a strong performance in both individual and group credit life insurance segments, with individual insurance growing by 6% and group credit life insurance by 23%. The increase in new business and a slight decrease in the surrender and lapse ratio indicate a positive trend for the company, potentially enhancing its market position and stakeholder confidence.
Lifenet Insurance Company reported a 10% increase in the annualized premium of policies-in-force for September 2025 compared to the previous year, reaching 35,806 million yen. This growth reflects a 6% increase in individual insurance and a significant 25% rise in group credit life insurance. The company also saw an increase in the number of new business policies and a slight improvement in the surrender and lapse ratio, indicating a strong operational performance.
Lifenet Insurance Company announced that its Board of Directors has discussed initiatives to implement management strategies that are conscious of cost of capital and stock price. This move indicates the company’s effort to enhance its operational efficiency and potentially improve its market positioning, which could have significant implications for stakeholders.
Lifenet Insurance Company reported a significant increase in their annualized premium of policies-in-force for August 2025, reaching 35,586 million yen, which is 110% of the previous year. This growth reflects a robust performance in both individual and group credit life insurance segments, with individual insurance premiums rising to 27,553 million yen and group credit life insurance premiums increasing to 8,032 million yen. The company’s improved performance indicates a positive trajectory in its market positioning and potential benefits for stakeholders.